Those prioritizing tolerability over maximum loss also benefit from such programs, as will some highly responsive individuals
Consider your medical history BMI and Comorbidities: GLP-1 agonists: Weight loss medications are an approved treatment for people with a Body Mass Index (BMI) over 30, or a BMI over 27 with at least one comorbidity like type 2 diabetes, hypertension or sleep apnea
The best choice depends on your goals, medication sensitivity, side effect concerns, weight loss timeline, and provider guidance
Semi-annual blood testing (available at a special cash rate) along with personalized medical review will provide you with a health baseline and insight into how optimizing your weight and metabolism is positively impacting your biomarkers
Initially approved for glycemic control in type 2 diabetes mellitus, their clinical application has expanded into obesity management, cardiovascular risk reduction, and metabolic syndrome modulation